About our Medical Products Technologies
At Ingenew Pharma, we are leveraging our fundamental understanding of immunology and inflammatory process to advance therapeutic solutions initially in the field of oncology, neurology, dermatology and urology. We remain opportunistic with regards to therapeutic fields whenever our core competencies can contribute to address unmet medical needs, our initiative for COVID-19 being one example.
Products
Indications
Discovery
Pre-clinical
Clinical
Market
HesperCo™
COVID-19
ING-012
Eczema
ING-035
Actinic Keratosis
ING-12
Neuro-cognitive
ING-260
Basal Cell Carcinoma
ING-251
Squamous Cell Carcinoma
ING-242
Interstitial cystitis
ING-332
Glioblastoma
ING-224
Melanoma
Products
HesperCo™
Indications
COVID-19
Discovery
Pre-Clinical
Clinical
Market
Products
Melanoma
Indications
Eczema
Discovery
Pre-Clinical
Clinical
Market
Products
ING-035
Indications
Actinic Keratosis
Discovery
Pre-Clinical
Clinical
Market
Products
ING-12
Indications
Neuro-cognitive
Discovery
Pre-Clinical
Clinical
Market
Products
ING-260
Indications
Basal Cell Carcinoma
Discovery
Pre-Clinical
Clinical
Market
Products
ING-251
Indications
Squamous Cell Carcinoma
Discovery
Pre-Clinical
Clinical
Market
Products
ING-242
Indications
Interstitial cystitis
Discovery
Pre-Clinical
Clinical
Market
Products
ING-332
Indications
Glioblastoma
Discovery
Pre-Clinical
Clinical
Market
Products
ING-224
Indications
Melanoma
Discovery
Pre-Clinical
Clinical
Market